The need of radiotherapy optimization for glioblastomas considering immune responses

Glioblastoma is the most common of malignant primary brain tumors and one of the tumors with the poorest prognosis for which the overall survival rate has not significantly improved despite recent advances in treatment techniques and therapeutic drugs. Since the emergence of immune checkpoint inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishioka, Kentaro, Takahashi, Shuhei, Mori, Takashi, Uchinami, Yusuke, Yamaguchi, Shigeru, Kinoshita, Manabu, Yamashina, Masaaki, Higaki, Hajime, Maebayashi, Katsuya, Aoyama, Hidefumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543135/
https://www.ncbi.nlm.nih.gov/pubmed/37071249
http://dx.doi.org/10.1007/s11604-023-01434-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543135/
https://www.ncbi.nlm.nih.gov/pubmed/37071249
http://dx.doi.org/10.1007/s11604-023-01434-x

Ejemplares similares